![]() Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. New tobacco products sold in the United States are subject to FDA regulation therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. You can contact us here on or through our social media channels on LinkedIn, Twitter, and Facebook. Let us all work together for the larger public health good. I call on the scientific and academic community and policy makers to look at the scientific work going on here at PMI with an unbiased eye and open mind. We keep the interests and welfare of the people for whom we have developed these products - adults who currently smoke - in the forefront and are doing science with the highest level of quality and integrity. ![]() I feel privileged to lead this team of exceptional scientists. also showcases our expertise spanning many fields of research: basic science, biology, toxicology, inhalation delivery science and technology, regulatory, quality, and clinical science. This website was built to summarize our scientific work and as a way to share our research that is the foundation of our smoke-free products in addition to publications in peer-reviewed journals. Here again, we have already demonstrated that switching to THS can have a positive impact on smokers’ health.Īs we did in the past, our results will be published on. Moving forward, and building on the past decade of experience, capabilities, and scientific work, we have started to execute a significant program of biomarker and clinical outcome studies to demonstrate individual clinical and public health benefit of our smoke-free products. Already, we have demonstrated that our tobacco heating system (THS) significantly reduces the formation of and exposure to harmful chemicals compared to cigarettes. Our aim is to assess and demonstrate the harm reduction potential of these alternatives to cigarettes. And we will continue to do so.Īt PMI Science, we are working to expand the body of scientific evidence related to our smoke-free products. This is why Philip Morris International (PMI) has spent years disrupting its core cigarette business by developing, assessing and marketing non-combustible alternatives to cigarettes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |